Antonia Cagnetta Selected Research

Daunorubicin (Cerubidine)

1/2018

Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells' vulnerability to DNA-damaging agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonia Cagnetta Research Topics

Disease

13	Neoplasms (Cancer) 10/2020 - 08/2012
11	Multiple Myeloma 02/2023 - 08/2012
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2021 - 10/2011
5	Leukemia 10/2020 - 01/2011
4	Hematologic Neoplasms (Hematological Malignancy) 10/2020 - 06/2009
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2020 - 09/2010
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2023 - 12/2016
2	Paraproteinemias (Monoclonal Gammopathy) 01/2023 - 01/2020
2	Residual Neoplasm 11/2021 - 01/2019
2	Genomic Instability 03/2016 - 01/2015
1	Carcinogenesis 10/2020
1	Anemia 09/2020
1	Lymphoma (Lymphomas) 01/2020
1	Starvation 01/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017
1	Neoplasm Metastasis (Metastasis) 01/2016
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 09/2015
1	Breast Neoplasms (Breast Cancer) 12/2014
1	Ischemia 01/2013
1	Inflammation (Inflammations) 01/2013
1	Acute Lung Injury 01/2013
1	Immune System Diseases (Immune Disorders) 01/2013
1	Bone Resorption 08/2012
1	Osteolysis 08/2012
1	Wilms Tumor (Wilm's Tumor) 10/2011

Drug/Important Bio-Agent (IBA)

9	NAD (NADH)IBA 02/2023 - 01/2011
6	Nicotinamide PhosphoribosyltransferaseIBA 01/2017 - 01/2013
4	EnzymesIBA 01/2017 - 10/2012
3	Proteins (Proteins, Gene)FDA Link 10/2020 - 12/2014
3	ibrutinibIBA 10/2020 - 08/2012
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020 - 01/2018
2	Monoclonal AntibodiesIBA 02/2023 - 05/2014
2	Agammaglobulinaemia Tyrosine KinaseIBA 10/2020 - 08/2012
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2015
2	Histone Deacetylases (Histone Deacetylase)IBA 03/2016 - 01/2011
2	B-Cell Maturation AntigenIBA 01/2016 - 05/2014
2	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2016 - 05/2014
2	N- (4- (1- benzoylpiperidin- 4- yl)butyl)- 3- (pyridin- 3- yl)acrylamideIBA 09/2015 - 06/2009
2	Vorinostat FDA Link 01/2013 - 01/2011
2	Histone Deacetylase InhibitorsIBA 01/2013 - 01/2011
1	NAD degrading enzymeIBA 02/2023
1	CD40 Ligand (CD40L)IBA 01/2023
1	daratumumabIBA 01/2023
1	venetoclaxIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 10/2020
1	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2020
1	Tyrosine (L-Tyrosine)FDA Link 10/2020
1	ARQ531IBA 10/2020
1	Phosphotransferases (Kinase)IBA 10/2020
1	RNA (Ribonucleic Acid)IBA 10/2020
1	Erythropoietin FDA Link 09/2020
1	Imatinib Mesylate (Gleevec)FDA Link 09/2020
1	Untranslated RNA (Noncoding RNA)IBA 01/2020
1	Amino Acids FDA Link 01/2020
1	carfilzomibIBA 01/2020
1	Rituximab (Mabthera)FDA Link 01/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020
1	Asparaginase (Elspar)FDA Link 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020
1	fludarabineIBA 01/2019
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2019
1	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2018
1	nicotinate phosphoribosyltransferaseIBA 01/2017
1	Interleukin-10 (Interleukin 10)IBA 01/2016
1	LigandsIBA 01/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2016
1	B7-H1 AntigenIBA 01/2016
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2015
1	Antineoplastic Agents (Antineoplastics)IBA 12/2014
1	Immunoconjugates (Immunoconjugate)IBA 05/2014
1	belantamab mafodotinIBA 05/2014
1	Bortezomib (Velcade)FDA Link 08/2013
1	Messenger RNA (mRNA)IBA 02/2013
1	Neutralizing AntibodiesIBA 01/2013
1	Chemotactic FactorsIBA 01/2013
1	PanobinostatIBA 01/2013
1	Mechanistic Target of Rapamycin Complex 1IBA 10/2012
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 10/2012
1	Macrophage Colony-Stimulating FactorIBA 08/2012
1	NucleophosminIBA 10/2011
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 10/2011
1	AnthracyclinesIBA 10/2011
1	Sirtuin 1IBA 01/2011
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2011
1	Butyric Acid (Butanoic Acid)IBA 01/2011
1	SirtuinsIBA 01/2011
1	cambinolIBA 01/2011
1	sirtinolIBA 01/2011
1	Dasatinib (BMS 354825)FDA Link 09/2010

Therapy/Procedure

6	Therapeutics 02/2023 - 10/2011
1	Stem Cell Transplantation 11/2021
1	Transplantation 01/2020